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Abstract
The post-transcriptional control of gene expression is becoming increasingly important in the
understanding of regulated events in eukaryotic cells. The parasitic kinetoplastids have a unique
reliance on such processes, because their genome is organized into polycistronic transcription
units in which adjacent genes are not coordinately regulated. Indeed, the number of RNA-binding
proteins predicted to be encoded in the genome of kinetoplastids is unusually large, invoking the
presence of unique RNA regulators dedicated to gene expression in these evolutionarily ancient
organisms. Here, we report that a small CCCH zinc finger protein, TbZFP3, enhances
development between life-cycle stages in Trypanosoma brucei. Moreover, we demonstrate that
this protein interacts both with the translational machinery and with other small CCCH proteins
previously implicated in trypanosome developmental control. Antibodies to this protein also co-
immunoprecipitate EP procyclin mRNA and encode the major surface antigen of insect forms of
T. brucei. Strikingly, although TbZFP3 is constitutively expressed, it exhibits developmentally
regulated association with polyribosomes, and mutational analysis demonstrates that this
association is essential for the expression of phenotype. TbZFP3 is therefore a novel regulator of
developmental events in kinetoplastids that acts at the level of the post-transcriptional control of
gene expression.
Regulatory events in prokaryotic and eukaryotic organisms are most commonly governed by
transcriptional control. In this way transcription factors and their co-regulators can target the
promoters for individual genes or coordinately regulated gene networks enabling either a
specific response to an environmental change or a programmed and more widespread
response through cell differentiation.
Gene regulation can also operate post-transcriptionally, either at the level of RNA
processing, mRNA stability, translational efficiency, protein localization, or turnover (1).
The extent of post-transcriptional control of gene expression differs between different genes,
networks, cells, and organisms. One group of organisms that has an unusual emphasis on
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post-transcriptional control is the kinetoplastid protozoa, comprising the important human
pathogens, Trypanosoma brucei, Trypanosoma cruzi, and Leishmania sp. (2). These
organisms, among the most evolutionarily ancient eukaryotes, are unusual in that their
genome is organized into long polycistronic transcription units with tens of genes being
coordinately transcribed from distant, as yet unidentified, promoters (3). Such co-transcribed
gene clusters do not seem, in general, to be organized as co-regulated operons; instead
adjacent genes can show differential gene expression, for example in different life-cycle
stages. This places the emphasis of gene regulation in these organisms almost entirely at the
post-transcriptional level. However, although the kinetoplastids conserve the conventional
eukaryotic machinery for mRNA turnover (4), little is known about the specific trans-acting
factors that govern developmental events at the level of gene expression. Moreover,
transcriptional control has only been observed for two protein-coding transcription units in
T. brucei: those encoding the variant surface glycoprotein gene (in bloodstream forms of the
parasite) and procyclin genes, which encode a protein coat on the forms of the parasite
found in its tsetse fly vector (reviewed in Ref. 2). In contrast to the remainder of
trypanosome transcription units these are unique in being transcribed by RNA polymerase I
(5, 6).
Differentiation between bloodstream and tsetse-midgut (procyclic) forms of T. brucei entails
a large number of fundamental changes in these unicellular protozoa (7). In addition to the
aforementioned surface antigen exchange, these include changes in cell morphology (8),
organelle development and activity (9), metabolism (10, 11), and cell-cycle control (12-14).
Usefully, if differentiation is initiated with a subtype of the bloodstream parasite population
that accumulates to near homogeneity at the peak of each parasitemia (i.e. stumpy forms),
then cell differentiation is almost completely synchronous in the population (15). This has
allowed a mapping of the events in this developmental pathway, thus revealing a high order
of temporal and spatial regulation. It has also allowed the identification of molecules
transiently enriched during this process. One such protein, TbZFP1, has been found to be
important for repositioning of the kinetoplast (an elaborated mitochondrial genome) from
the posterior end of the cell to a position midway between the nucleus and cell posterior (16,
17). This is one of the major morphological events that characterize differentiation between
bloodstream and procyclic forms and is mediated by posterior outgrowth of the trypanosome
microtubule corset (8). A related protein, TbZFP2, also generates a procyclic stage-specific
morphological phenotype when overexpressed and is required in bloodstream forms for
efficient differentiation, as revealed by transcript-specific RNAi3 (16).
TbZFP1 and TbZFP2 are members of a family of proteins characterized by their possession
of the zinc finger motif C7-8C5C3H (CCCH) and small size (<150 amino acids). Although
TbZFP1 and -2 are unique to kinetoplastids, the CCCH motif is an RNA binding zinc finger
found in a range of eukaryotic proteins involved at all levels of post-transcriptional gene
expression control (18-21). In particular, the mammalian tristetraprolin (TTP) family of
proteins recognize AU-rich elements in the 3′-untranslated region of mRNAs causing
3The abbreviations used are:
RNAiRNA interference
TTP tristetraprolin
E3 ubiquitin-protein isopeptide ligase
BD binding domain
AD activation domain
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regulated instability (18), whereas in Caenorhabditis elegans regulated control of translation
and mRNA localization during embryonic development is conferred by POS1 (22), MEX3
(23), and PIE-1 (19). Consistent with this, the homologue of TbZFP1 in T. cruzi has been
shown to bind RNA and interact with identified regulatory RNA elements that control
developmental gene expression (24). Notably, TbZFP1 and -2 also contain protein-
interaction domains with TbZFP2 possessing a WW motif closely related to one of those
found in E3 ubiquitin ligases.
The recent completion of the genome sequence for three kinetoplastids reveals an unusual
number of CCCH proteins encoded in each organism, with 65 predicted CCCH proteins
encoded in T. brucei, compared with 12 in Schizosaccharomyces pombe (4). Among this set,
a third small CCCH protein has been identified, which enhances trypanosome life-cycle
differentiation. Moreover, analysis of the interactions of TbZFP3 in vivo demonstrates its
capacity to complex with both TbZFP1 and TbZFP2. This supports a modular model for
functional interactions among this unusual protein family, each of which has been
implicated in the regulation of differentiation events. Finally, we demonstrate that TbZFP3
exhibits a procyclic stage-specific association with polyribosomes despite its constitutive
expression through the life cycle and that this association is necessary for the expression of
phenotype. This supports a role for this unique protein family in the post-transcriptional
control of developmental events in the trypanosome life cycle.
EXPERIMENTAL PROCEDURES
Trypanosomes
For ectopic expression, T. brucei 427 bloodstream and procyclic forms were used, each
being previously engineered to express the tetracycline repressor protein, enabling regulated
gene expression. Slender and stumpy form RNA, protein extracts, and polysomal extracts
were prepared from T. brucei rhodesiense EATRO 2340. Stumpy forms were isolated 5-6
days after inoculation of mice with 1 × 105 T. brucei rhodesiense EATRO 2340 GUP2962
when the population was >80% stumpy by morphology. Parasite transfection was carried out
as previously described (16), with procyclic cells being cultured in SDM-79 and selected
with 20 μg/ml hygromycin, whereas bloodstream forms were cultured in HMI-9 (at 37 °C,
5% CO2) and selected with 2 μg/ml hygromycin.
Plasmid constructs were each generated in the trypanosome expression vector pHD451 (30).
Deletion and mutation of TbZFP3 were carried out either via the Stratagene mutate-a-base
mutagenesis kit or by a PCR mutagenesis strategy. Complete details of plasmid
constructions in this report, and associated primers, are available from the authors upon
request.
Northern and Western Blotting, Immunoprecipitation, and Polysome Fractionation
RNA was prepared from bloodstream or procyclic forms using an RNeasy RNA isolation kit
(Qiagen), and RNAs were resolved on 1% formaldehyde gels. Hybridization was carried out
using digoxigenin-labeled Riboprobes with post hybridization washes being carried out at 68
°C, 0.1× SSC. Signal detection was via chemiluminescence using CDP-Star (Roche Applied
Science) as a reaction substrate.
Protein extracts were prepared from 1 × 106 bloodstream or procyclic forms in Laemmli
sample buffer. Samples were transferred to nitrocellulose membranes via electroblotting,
and effective transfer was verified by Ponceau staining. Blots were blocked with 5%
powdered milk in phosphate-buffered saline overnight and then incubated with 1/500
dilution (in 5% milk in phosphate-buffered saline) of anti-TbZFP3 antibody, this being
raised against the peptide antigen N-DSSQMQQVGHDVPPMA-C in rabbits (by
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Eurogentec, Belgium). After incubation with a 1/5000 dilution of anti-rabbit IgG-
horseradish peroxidase conjugate (Dako), signals were detected via chemiluminescence.
For immunoprecipitation, 1-5 × 108 cells were pelleted and then snap frozen before
resuspension in 0.5 ml of IP-150 lysis buffer (10 mM Tris-Cl, pH 8, 150 mM NaCl, 1%
Nonidet P-40, 0.5 mM EDTA). After 25-30 strokes in a Dounce homogenizer, the cell extract
was cleared by microcentrifugation (10,000 × g for 10 min at 4 °C) and used directly for
immunoprecipitation, or centrifuged at 100,000 × g in a Beckman TLA100.3 rotor to yield a
S100 supernatant or pellet. For immunoprecipitation cell extracts were incubated at 4 °C 1 h
overnight with antibody (1:500), or with antibody preincubated with the peptide antigen (40
μg) to which it was raised (as a negative control). Washed protein G beads were then
incubated with the extract for a further 1 h and pelleted by centrifugation at 10,000 × g for
10 min, yielding the flow-through. The beads were washed 6-9 times with IP-150 lysis
buffer, and then bound proteins were extracted into boiling Laemmli sample buffer. For
RNA immunoprecipitation, the same procedure was used with RNA being isolated in IP-150
lysis buffer plus 1% SDS at 65 °C, and then purified by phenol/chloroform extraction and
ethanol precipitation. RNA retrieved from each sample was divided into two reverse
transcription reactions using dT18Anchor (GCGCCGGCGCCTCAGCG) primer at 42 °C for
1 h. Equivalent quantities of cDNA obtained from all samples was amplified using the
primers 5′-EP1 GGTGCTGCAACGCTGAAATCTGTTGC, or Actin 5′-
GTATAGCGTGTGGATTGGCGGTTCC in combination with dT18Anchor at 65 °C for up
to 35 cycles.
For polysome fractionation 0.5-1 × 109 cells were incubated for 10 min with 100 μg/ml
cycloheximide and then centrifuged and resuspended in 25 ml of phosphate-buffered saline
containing cycloheximide and washed once. The cells were then resuspended in 1 ml of
polysome buffer (20 mM Tris-Cl, pH 7.5, 120 mM KCl, 2 mM MgCl·6H2O, 1 mM
dithiothreitol, 22 μM leupeptin, with 2 μl of RNasin per milliliter) containing cycloheximide,
centrifuged at 1,000 × g, resuspended in 0.5 ml of polysome buffer, and subjected to 20
strokes in a Dounce homogenizer with Nonidet P-40 being added to 1.2%. The lysate was
cleared by centrifugation at 1,000 × g. The lysate was then fractionated on a 15-50% sucrose
gradient at 240,000 × g in a Beckman SW40Ti rotor, and fractions were collected using a
peristaltic pump connected to an AKTA Basic high-performance liquid chromatograph and
fraction collector, with RNA concentration being monitored at 254 nm.
Cell Image Acquisition and Morphometric Analysis
Cells were processed for immunofluorescence as previously described. Kinetoplast-posterior
measurements were taken using Scion image 1.62. Cell images were captured using a Zeiss
Axioscop 2 and processed using Adobe Photoshop CS.
Yeast Two-hybrid Analysis
The Matchmaker system 3 (Clontech) was used throughout, and protocols were followed
according to the manufacturer’s instructions with the following exceptions: the LexA DNA
binding domain plasmid pSTT91 (25) was digested with EcoR1/BamH1to allow for in-
frame ligation of the relevant TbZFP coding region. The activation domain plasmid
pGADT7 was created using an EcoR1/XhoI digestion allowing the insertion of the
appropriate TbZFP open reading frame. Co-transformation of 1 μg of both these fusion
plasmids into the L40 yeast strain (26) was achieved using the high efficiency polyethylene
glycol/lithium acetate method (27), and double transformants were selected on plates
lacking Leu and Trp. Activation of the His3 reporter gene by reconstitution of the GAL4
transcription factor encoded in the fusion proteins was characterized by growth on plates
lacking Leu/Trp/His/Ade. Activation of the β-galactosidase reporter gene was observed by
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replica-plating the colonies onto nylon membrane (Amersham Biosciences) on a YPDa
plate, incubating for 16 h, and then performing a colony lift assay (28).
RESULTS
We searched the T. brucei genome sequence data base (www.geneDB.org) using the
TbZFP1 and TbZFP2 protein sequences to identify further members of this protein family.
This identified an open reading frame (Tb927.3.720) encoding a 130-amino acid predicted
protein comprising a CCCH domain toward its C terminus and a WW protein-interaction
domain toward its N terminus (Fig. 1A). This matched the overall motif organization of
TbZFP2 (Tb11.01.6590), which has been previously characterized to have a role in
trypanosome differentiation and posterior end morphogenesis (16). Similar to TbZFP2, the
WW domain in the newly identified protein was most similar to a particular WW domain in
E3 ubiquitin ligases. Unlike TbZFP2, however, TbZFP3 also possessed three intact copies of
the RGG-predicted RNA-binding motif positioned centrally between the WW and CCCH
domain. The newly identified gene has been recently described in the context of a
bioinformatic analysis of homologous genes in T. cruzi and has been named TcZFP2b (29).
However, although they share several motifs associated with molecular interactions, the
primary amino acid sequences of TbZFP2a and -b are dissimilar (Fig. 1A), and their genes
are unlinked. Therefore, we prefer to denote this by renaming of the new molecule TbZFP3.
The previously characterized differentiation regulator TbZFP1 is silenced in bloodstream
forms at the protein level but is transiently elevated during differentiation to procyclic forms
where expression is then retained (16, 17). In contrast, TbZFP2 is expressed equally in
bloodstream and procyclic forms and exhibits uniform expression throughout synchronous
differentiation between stumpy and procyclic forms (16). To address whether TbZFP3 is
regulated during the parasite life cycle, we examined the mRNA and protein levels for this
gene in bloodstream and procyclic forms. Fig. 1B demonstrates that this 390-bp-coding
region is contained within an mRNA of ~1.9 kb that is expressed equally in slender and
stumpy bloodstream forms and in procyclic forms. To verify that the gene was translated
into protein and to examine its expression profile, an anti-peptide antibody was raised to the
sequence N-DSSQMQQVGHDVPPMA-C, this being located at the extreme C terminus of
TbZFP3 protein. When reacted with protein derived from bloodstream monomorphic forms
and procyclic forms, a band was detected at the predicted molecular mass for TbZFP3 (14
kDa) in each life-cycle stage, and at approximately equal levels, consistent with the RNA
profile (Fig. 1B). The profile of TbZFP3 protein expression was also assayed during
synchronous differentiation between bloodstream stumpy forms and procyclic forms, after
culture in SDM-79 medium at 27 °C containing 6 mM cis-aconitate (Fig. 1C). This
demonstrated approximately equivalent expression throughout differentiation with no
evidence for a transient elevation in expression during this synchronous transition. This
matched the expression profile of TbZFP2 but differs from TbZFP1, which is elevated in
expression level around 4-8 h through differentiation (16). Therefore, TbZFP3 is
consistently expressed in both bloodstream and procyclic forms and during synchronous
differentiation between these forms.
Ectopic Expression of TbZFP3 Induces Enhanced Differentiation
Prior knockdown of TbZFP2 in bloodstream forms by RNAi had resulted in decreased
efficiency of differentiation as assessed by gain of the insect-stage-specific antigen, EP
procyclin (16). This implicated TbZFP2 in the control of early differentiation events,
contrasting with TbZFP1, which appears to act later in the differentiation program (17). To
determine whether TbZFP3 also had a role in developmental control, we initially attempted
RNAi for this molecule in bloodstream forms. Although viable cell lines were generated
using several available RNAi vectors, effective reduction of TbZFP3 protein was not
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achieved (a maximum reduction of 60% was observed, data not shown). However, cell lines
were generated in which tetracycline-regulated ectopic overexpression of TbZFP3 was
possible. Specifically, a copy of TbZFP3 encoding a C-terminal Ty1 epitope tag (denoted
TbZFP3-Ty) was inserted into the trypanosome expression vector pHD451 (30) and
transfected into T. brucei 427 monomorphic bloodstream forms, which express the
tetracycline repressor protein. The resulting cell lines were then induced to express TbZFP3-
Ty by the addition of tetracycline, this being monitored by Western blotting using the
TbZFP3-specific anti-peptide antibody allowing simultaneous detection of the endogenous
and transgenic protein. Fig. 2B (Day 0 samples) shows inducible ectopic expression of
TbZFP3-Ty in bloodstream forms was achieved, generating a combined 1- to 2-fold
overexpression of TbZFP3 compared with wild-type cells.
Having successfully generated a cell line capable of perturbed TbZFP3 expression we
examined the consequences of this for the efficiency of differentiation to procyclic forms.
Specifically, parental or TbZFP3-Ty-transfected bloodstream forms were induced, or not,
with tetracycline for 3 days in culture, and then differentiation was initiated under standard
conditions. Thereafter, EP procyclin expression was followed daily via
immunofluorescence, with protein samples also being prepared to monitor TbZFP3-Ty
expression. Fig. 2A (days 1-3 samples) shows the result of four such experiments, which
revealed that ectopic expression of TbZFP3-Ty resulted in enhanced EP procyclin
expression in the population. Thus, at each time point after the induction of differentiation
the proportion of EP procyclin expressers was consistently up to 2-fold higher than in
uninduced or parental controls (either in the presence or absence of tetracycline). This
correlated with the detection of the ectopically expressed protein by Western blotting (Fig.
2B). To complement this IFA-based counting assay (which qualitatively scores cells as
being “+” or “-” on an individual cell basis), differentiation was also scored in an
independent experiment by flow cytometry for EP expression at the population level (Fig.
2C). This confirmed enhanced differentiation upon TbZFP3-Ty expression with the induced
cell line demonstrating 69% EP-procyclin expression compared with 53% in the uninduced
control at 72 h after the initiation of differentiation. We verified that this effect was not due
to the increased expression of stumpy characteristics via a number of assays for that life-
cycle stage and found no consistent difference from uninduced cells (refer to the
supplemental data). Therefore, ectopic expression of TbZFP3 results in enhanced
differentiation to procyclic forms as assessed by EP procyclin expression, consistent with
the reduced efficiency of this process upon knockdown of TbZFP2 by RNAi (16).
Combined with the specific inhibition of kinetoplast repositioning induced by genetic
ablation of TbZFP1 (17), this supports the role for this family of proteins in differentiation
processes.
Ectopic Expression in Procyclic Forms Causes a Characteristic Morphological Phenotype
In addition to the bloodstream form cell lines, ectopic expression of TbZFP3 was also
investigated in procyclic forms (Fig. 3A). In this case, upon induction of TbZFP3-Ty
expression, the cell population was found to produce elongated cells reminiscent of the
nozzle phenotype previously observed upon ectopic expression of TbZFP2 (16) (Fig. 3B).
As with TbZFP2 expression, cell elongation upon TbZFP3 expression involved posterior
microtubule extension as revealed by YL1/2 staining of tyrosinated α-tubulin in the
trypanosome cytoskeleton (data not shown). However, unlike with ectopic TbZFP2
expression, where nozzle formation was entirely restricted to cells with 1 kinetoplast and 1
nucleus (i.e. G1 and S phase cells), in cells expressing ectopic TbZFP3-Ty ~15% of cells
with an extended posterior had segregated their kinetoplast. This is indicative of cell cycle
progression into G2, consistent with a similar phenotype observed upon RNAi ablation of
the cyclin, CYC2 (31).
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The manifestation of the nozzle morphology provided a convenient and quantifiable
phenotypic assay with which to dissect important domains in TbZFP3. Specifically we
wanted to evaluate whether the WW domain and CCCH RNA binding domain in TbZFP3
were essential for morphological extension. Therefore, we generated a series of cell lines in
which either the WW or CCCH domain in TbZFP3 were deleted from the ectopically
expressed protein, or in which a single amino acid change was introduced to mutate the
CCCH motif to the sequence CCAH. Finally, we generated a cell line in which the Ty tag
was absent from the transgenic protein thereby ensuring that phenotypic effects were a result
of the native protein and not the introduction of the tag. Fig. 4A shows that in each case the
ectopic proteins were effectively expressed in the transgenic cell lines. The relative
expression between induced and uninduced samples varied somewhat, but in each the level
of the induced protein expression was similar. Having verified effective and comparable
expression levels for each protein, we then assayed the degree of morphological extension
by measuring the kinetoplast to posterior dimension in 100 cells in each population. This
analysis, shown in Fig. 4B, demonstrated that, whereas the presence or absence of the Ty tag
was not important in nozzle formation, deletion of the WW or CCCH domain, or
introduction of a mutation to disrupt the CCCH domain, each significantly abrogated nozzle
formation. Thus ectopic expression of either native or Ty-tagged TbZFP3 generated a mean
kinetoplast-posterior dimension of 10.31 μm (±0.35 μm (S.E.)) and 9.52 μm (±0.24 μm)
respectively, whereas the values generated for each mutant were: ΔWW, 5.24 μm (±0.21
μm), ΔCCCH 5.40 μm (±0.21 μm), and CCAH, 5.88 μm (±0.19 μm), with these
approximating to the kinetoplast-posterior dimension in wild-type procyclic forms of 5.41
μm (±0.18 μm). We conclude that the CCCH and WW domains in TbZFP3 are both
individually important for generation of the nozzle phenotype.
Molecular Interactions of the TbZFP Protein Family
We have proposed that members of the TbZFP family may interact on the basis of
complementary protein interaction domains whereby TbZFP2 and -3 each contain a WW
domain, and TbZFP1 contains the complementary target PPPPPY motif (16). To investigate
this potential, the ability of TbZFP1, TbZFP2, and TbZFP3 to interact in a pairwise yeast
two-hybrid interaction screen was assayed. Thus fusion proteins of TbZFP1, TbZFP2, and
TbZFP3 were generated in bait and prey plasmids, which allowed expression of each TbZFP
fused to either the LEXA DNA binding domain (BD) or the GAL4 activation domain (AD).
In each case mutants, in which the WW domain in both TbZFP2 and -3 were deleted, were
also generated to establish their function in potential interactions with TbZFP1. These
molecules were then co-transformed pairwise into yeast and colonies streaked onto
nonselective (-TRP and -LEU) or selective (-ADE and -HIS) plates, as well as being assayed
for LacZ production.
The data in Fig. 5 indicate that TbZFP1 is able to directly interact with TbZFP2 and -3, this
evidenced by the production of LacZ and activation of nutritional markers on -TRP, -LEU, -
HIS, and -ADE plates (2DB+1AD and 3DB+1AD, Fig. 5). Moreover, this interaction is
mediated by the WW motif alone, because deletion of this motif in TbZFP2 (2DBΔww
+1AD, Fig. 5) or TbZFP3 (3DBΔww+1AD, Fig. 5) abolishes the interaction of each with
TbZFP1. Although a weak potential interaction was observed between the TbZFP2-LexA
DNA BD fusion and the TbZFP3-Gal4AD fusion (2DB+3AD, Fig. 5), this was not
reciprocated when the bait and prey were reversed and is likely to be artifactual. Thus, there
appears to be no direct interaction between TbZFP2 and TbZFP3 and we found no evidence
that these proteins can homodimerize. However, TbZFP1 can interact with TbZFP2 or
TbZFP3 with the WW protein binding motifs being essential in this.
Although two-hybrid analysis can prove informative for direct protein interactions in vitro, it
was also important to validate potential interactions between these proteins in vivo.
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Therefore, the ability of the antibody against TbZFP3 to co-immunoprecipitate TbZFP2 and
TbZFP1 was investigated in procyclic cell extracts, with specificity being verified by
blocking with the peptide antigen used to raise the antibody. Fig. 6A demonstrates that
TbZFP1, -2, and -3 were each co-immunoprecipitated with anti-TbZFP3 antibody and that
this was efficiently blocked by the peptide immunogen. These experiments confirm that
TbZFP1 can interact directly with TbZFP2 and TbZFP3 in vitro and that all three proteins
can be co-immunoprecipitated in vivo suggesting their involvement in overlapping or the
same protein complex(es).
Cell Fractionation of TbZFP3 Reveals Stage-specific Association with Polyribosomes
To analyze further the cellular location and interactions of TbZFP3, the distribution of this
protein among different cellular compartments was investigated by cell lysis and differential
detergent extraction. This resolved trypanosome proteins into cytosolic, nuclear, organellar
vesicles/plasma membrane, or cytoskeletal fractions. Fig. 6B demonstrates that the majority
of TbZFP3 co-fractionated with cytosolic proteins in both bloodstream and procyclic forms,
with a small proportion fractionating with cell organelles/plasma membrane, this most
probably representing some cytosolic contamination of this fraction. This distribution was
matched by TbZFP2. Consistent with a cytosolic location, immunofluorescence of TbZFP3
in procyclic forms (fixed by paraformaldehyde in the presence of 0.1% Triton X-100)
revealed a uniform staining pattern through the cell, without concentration in any
recognizable organelle (data not shown).
Cell extracts were also analyzed by differential centrifugation, revealing a distribution of
TbZFP3 between S100 supernatant and pellet (data not shown). This suggested the
possibility of association of TbZFP3 with polysomes in procyclic forms. To investigate this
further, procyclic cell extracts prepared in polysome buffer in the presence of cycloheximide
were separated on 15-50% sucrose gradients, and fractions were analyzed for the presence
of TbZFP3, BiP (a non-polysomal endoplasmic reticulum protein) and ribosomal protein P0
(a ribosomal stalk component that fractionates with monosomes and polysomes). Fig. 7
shows that TbZFP3 distributed into monosomal (fractions 6-12) and polysomal fractions
(fractions 13-22) matching the distribution of P0, although TbZFP3 was also abundant in the
non-polysomal fractions, consistent with the bimodal distribution of TbZFP3 between the
S100 pellet and supernatant. Confirming the association of TbZFP3 with polysomes in
procyclic forms, TbZFP3 and P0 redistributed to lower molecular weight fractions in
EDTA-treated cell extracts (Fig. 7).
The stage-specific phenotypes resulting from TbZFP3 ectopic expression prompted us to
investigate the polysome association of this protein in bloodstream forms, as well as
procyclic forms. Interestingly, although TbZFP3 is expressed at similar levels in
bloodstream and procyclic forms, clear evidence for polysome association was only
observed in the latter (Fig. 8A). Thus, in bloodstream slender forms, TbZFP3 sedimented in
the low molecular weight fractions with a distinct distribution from the polysomal marker
P0. Similarly, in homogenous populations of bloodstream stumpy forms TbZFP3 was also
disassociated from polyribosomes, although the abundance of polysomes was considerably
reduced as expected in this quiescent life-cycle stage (32). This demonstrated that the
association of TbZFP3 with polysomal fractions was developmentally regulated, being
enriched in procyclic forms and absent in bloodstream slender and stumpy forms.
The stage-specific association of TbZFP3 with polyribosomes prompted us to further
determine whether ectopic expression of this protein perturbed its normal associations with
the translational apparatus in either bloodstream or procyclic forms. Thus, we examined the
distribution of endogenous and ectopic TbZFP3 in either transgenic procyclic forms (where
the nozzle phenotype is generated) or in bloodstream forms (which exhibit enhanced
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differentiation). More specifically, TbZFP3 was expressed in either procyclic forms for 48 h
(coinciding with the appearance of nozzle cells in the population) or in a bloodstream line
that can generate division-arrested intermediate/stumpy forms when grown in mice (33).
These cells were grown for 8 days in mice that had been supplied with doxycycline in their
drinking water (to induce TbZFP3-Ty expression), and then parasites were harvested for
analysis of the distribution of TbZFP3 on sucrose gradients. Fig. 8B demonstrates that in
both bloodstream and procyclic forms the ectopically expressed and endogenous TbZFP3
exactly co-sedimented, this being polysomal for procyclic forms and non-polysomal for the
bloodstream forms. We conclude that ectopically expressed TbZFP3 does not alter the
normal polysomal distribution of this protein, association of the translational apparatus
being enriched in procyclic forms regardless of the expression of ectopic TbZFP3.
Polysome Association Precisely Correlates with Both Nozzle Formation and Enhanced
Differentiation
In procyclic forms the morphological phenotype generated by TbZFP3 ectopic expression
was dependent upon the integrity of the WW and CCCH domain. To investigate whether
disruption of these domains resulted in disassociation of the ectopic protein from polysomes,
the distribution of endogenous and ectopically expressed TbZFP3 was analyzed on sucrose
gradients of procyclic cell extracts. In each case the ectopic and endogenous proteins were
detected using either the anti-Ty1 epitope tag antibody BB2 (to detect the ectopic protein
only) or the TbZFP3 antibody (detecting both endogenous and ectopic TbZFP3). Fig. 9
demonstrates that, when the ΔWW, ΔCCCH, or CCAH mutants were expressed in
procyclic forms, the ectopic protein fractionated into the non-polysomal or monosomal
region of the gradient, whereas endogenous TbZFP3 and the ribosomal marker P0 each
remained polysome-associated. This demonstrates that TbZFP3 associates with polysomes
only if its WW or CCCH domains are intact. This exactly correlates with the capacity of
each mutant to induce morphological extension as determined in Fig. 4.
Having determined that mutations that prevented polysome association also prevented
nozzle formation in procyclic forms, we investigated whether the same mutants also
disrupted enhanced differentiation of bloodstream forms. Therefore, stable bloodstream
trypanosome cell lines were generated expressing each of the TbZFP3 mutants (ΔWW,
ΔCCCH, and CCAH), and the expression of these was induced for 3 days by growth in
tetracycline. Thereafter, each was induced to initiate differentiation with cis-aconitate, and
the percentage of procyclin expressers quantified over the following 72 h by
immunofluorescence. Fig. 10 shows that, whereas ectopic expression of wild-type TbZFP3
enhanced differentiation as expected, the mutants with a disrupted WW or CCCH domain
each differentiated with an equivalent efficiency to wild-type parental cells. This
demonstrated that the phenotypes generated by ectopic expression of TbZFP3 in both
procyclic forms (nozzle formation) and bloodstream forms (enhanced differentiation) were
each dependent upon the integrity of the WW and CCCH domain in the protein. Moreover,
manifestation of these phenotypes exactly correlated with the ability of each protein to
associate with polysomes. This provides evidence for a cause-and-effect relationship
between the function of TbZFP3 and its association with the translational apparatus.
The enhanced differentiation phenotype induced by TbZFP3 ectopic expression was
detected by assay for the expression of EP procyclin protein. Therefore, we assessed
whether antibodies to TbZFP3 could co-immunoprecipitate EP procyclin mRNA. Fig. 11A
demonstrates that this was the case: EP procyclin mRNA was selected by antibody to
TbZFP3 (Fig. 11A, lane 1), and this was prevented in the presence of blocking peptide (Fig.
11A, lane 2). The specificity of this was confirmed by the absence of actin mRNA, a
constitutively expressed transcript, in the immunoprecipitated material (Fig. 11B). We
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conclude that TbZFP3 protein and EP procyclin mRNA co-precipitate in procyclic cells,
either directly or indirectly.
DISCUSSION
The control of cell differentiation in T. brucei is highly regulated, involving a series of
developmental steps that are temporally coordinated. This ensures the generation of a viable
cell upon differentiation from the bloodstream to the very different environment of the tsetse
midgut. The control of these cellular events requires changes in gene expression, this
effected by unknown regulatory factors that must operate at the post-transcriptional level. In
this report we demonstrate that a new member of a previously characterized family of
unusual small RNA-binding proteins is able to enhance differentiation when overexpressed.
Moreover, we demonstrate that TbZFP3 exhibits developmentally regulated co-fractionation
with polyribosomes. To our knowledge this is the first regulatory protein identified in these
organisms that controls differentiation capacity and shows life-cycle stage-specific
phenotypes via involvement at a specific step in the gene expression pathway, the
translational apparatus.
TbZFP3 was identified on the basis of its possession of a CCCH zinc finger domain. This
motif is characterized by its interaction with RNA in a number of regulatory proteins in
eukaryotic cells, including trypanosomes (24). The best characterized of these is the TTP
family of mRNA regulators, which destabilize specific cytokine transcripts important in
regulating immune responses. In TTP knock-out mice, dysregulation of tumor necrosis
factor-α and granulocyte macrophage-colony stimulating factor in macrophages is observed
as are changes in the abundance of at least two interleukin transcripts (reviewed in Ref. 34).
These changes are caused by binding of TTP to AU-rich elements in the 3′-untranslated
region of target mRNAs, resulting in their destabilization. In addition to TTP family
proteins, a number of different classes of CCCH-containing molecule with a diversity of
functions have subsequently been characterized in eukaryotic cells. These include the
regulation of flower development by HUA1 (35) and FES1 (36), proteins that protect against
viral infection by destabilization of retroposon transcripts (37), components of the mRNA
processing machinery (U2AF, CPSF30, suppressor of sable), and a number of
developmental regulators in C. elegans, which function via temporal and spatial regulation
of maternal mRNAs at several levels (transcription, mRNA processing, RNA localization,
and translation) (19, 38, 39).
The binding of CCCH-containing proteins to RNA is normally dependent upon the presence
of two tandemly arranged CCCH zinc finger motifs (40, 41), these being at precisely
conserved spacing. In contrast to this organization, TbZFP3, like the previously identified
TbZFP1 and TbZFP2, possesses only a single CCCH domain. Although one CCCH domain
is sufficient for RNA binding in vitro (27),4 we investigated whether TbZFP1, -2, or -3
could interact to generate a multicomponent complex (possibly an mRNP complex)
possessing more than one CCCH finger. Initially, yeast two-hybrid studies confirmed the
ability of TbZFP2 and -3 to interact with TbZFP1, this being mediated via the WW domain
in each protein. This matches the findings of a related study with an analogous protein
identified in T. cruzi (29), although in contrast to that study we did not find evidence that
TbZFP2 or TbZFP3 could homodimerize. More importantly, when we investigated the
association of TbZFP3 with TbZFP1 and TbZFP2 in vivo via co-immunoprecipitation we
found evidence for direct or indirect interaction between each protein, providing evidence
that these proteins can co-associate in the cell.
4P. Walrad and K. Matthews, unpublished observations.
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Analysis of the polysomal distribution of TbZFP3 revealed that this protein (and TbZFP2)4
showed stage-enriched association with the translational apparatus. Based on this surprising
observation, we propose that TbZFP3 operates as a trans-acting regulator to translationally
activate (or repress, if the protein acts on a negative regulator) specific mRNA subsets in a
developmentally regulated manner. This scenario is compatible with the phenotypes
observed in both procyclic and bloodstream forms when TbZFP3 is ectopically
overexpressed. Thus, in procyclic forms, posterior extension to generate nozzle forms
represents an exaggerated manifestation of the normal morphological changes that occur
during differentiation. In bloodstream forms, TbZFP3 ectopic expression would have no
consequence until differentiation was initiated, and the protein associates with the
translational apparatus. As in established procyclic forms, this would then result in the
robust expression of procyclic characteristics (e.g. procyclin expression and kinetoplast
positioning), this being manifested as more efficient differentiation. Therefore, direct or
indirect regulation of differentiation markers such as EP procyclin is possible, and indeed
we found that TbZFP3 is able to co-immunoprecipitate EP procyclin transcripts. This does
not indicate direct binding, although TcZFP1 from T. cruzi (related to TbZFP1 in T. brucei)
can directly interact with a procyclin regulatory element in vitro (24). Consistent with the
association of TbZFP3 with polysomes only after the initiation of differentiation to procyclic
forms, we observed no pre-expression of mRNA or protein for EP procyclin or the
procyclic-specific cytoskeletal protein CAP 5.5 upon TbZFP3 ectopic expression in
bloodstream forms.5
Several RNA-binding proteins regulate developmental pathways via translational control.
Examples include the Drosophila Bruno protein that interacts with the Oskar embryonic
mRNA and silences its translation via sequestration into silencing particles (42). Similarly,
in C. elegans the CCCH protein POS-1 controls embryonic development via translational
regulation of the maternal mRNA glp-1 (39). In another case, PIE-1 regulates the association
of mRNAs with stress granules, such that they are repressed (38). The paucity of
transcriptional control, and the polycistronic organization of the genome, make post-
transcriptional mechanisms the most important level for gene regulation in trypanosomes.
To date, most attention has focused on the role of differential mRNA stability for stage-
regulated transcripts. However, it is increasingly clear that translational control is also a
major component of regulated gene expression in trypanosomatids. This matches the
emerging picture for genes in other organisms in which developmental processes are
controlled via pre-existing mRNAs being held in a translationally inactive state (34, 43)
often by sequestration into ribonuclear granules (P bodies).
TbZFP3, like TbZFP2, is constitutively expressed. However, its association with other
RNA-binding proteins may modify its activity or substrate specificity. One of these
modulators may be TbZFP1. TbZFP1 is synthesized only after the initiation of
differentiation between bloodstream and procyclic forms such that association with TbZFP2,
or TbZFP3 (or a complex containing both proteins), may alter their target specificity. This
proposed modularization of function may allow these proteins to control the expression of
distinct cohorts of genes in different life-cycle stages, or at stages through development, in a
form of post-transcriptional operonic regulation (44). A general perturbation of protein
translation induced by TbZFP3 expression is ruled out by the observation that P0 does not
redistribute into monosomes upon ectopic TbZFP3 expression. Furthermore, general
translational inhibition in procyclic forms by hygromycin does not induce comparable
nozzle formation.5
5A. Paterou, P. Walrad, P. Craddy, K. Fenn, and K. Matthews, unpublished observations.
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The TbZFP family of RNA-binding proteins are present in kinetoplastid parasites but not in
other eukaryotes for which there is complete genome sequence information. Indeed, in
kinetoplastids there is over five times the number of CCCH proteins as in yeast. It is likely
that the unique reliance upon post-transcriptional control by the trypanosome genome
necessitates this plethora of novel RNA-binding proteins, which permit stringent and rapid
control of gene expression during the parasite life cycle. Although many of the core
components of the gene expression machinery in these parasites are conserved with their
hosts and vectors, it is those components that are not present in other organisms that provide
the key to understanding the unique complexity of gene regulation in these organisms. The
TbZFP family of CCCH proteins provides an excellent route into dissecting the molecular
interactions required for coordinating a developmental pathway almost completely
dependent on the post-transcriptional control of gene expression.
Supplementary Material
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FIGURE 1. Identification and expression of a novel CCCH protein
A, sequence alignment of TbZFP3 with TbZFP2, a previously identified small CCCH
protein in trypanosomes. The WW, RGG, and CCCH domains are boxed in each case,
highlighting the similarity in structural organization of the two sequences, despite their
lacking obvious primary sequence identity. B, expression profile of TbZFP3 during the
trypanosome life cycle. The left-hand panel shows a Northern blot of RNA derived from
bloodstream slender (SL), bloodstream stumpy (ST), and procyclic (PC) forms hybridized
with a TbZFP3 mRNA-specific Riboprobe. The transcript migrates at 1.9 kb, considerably
larger than the coding region of TbZFP3, suggesting the presence of untranslated regions
extending for ~1.5 kb. The right-hand panel shows protein expression of TbZFP3 in
monomorphic bloodstream forms (Bs) or procyclic (Pc) forms. The protein migrates at the
expected molecular mass (14 kDa). Staining with an antibody to trypanosome α-tubulin
(TAT1) provides a control for loading. C, TbZFP3 protein expression during synchronous
differentiation between a uniform population of bloodstream stumpy forms and procyclic
forms. Protein samples were prepared at 2-h intervals during differentiation to procyclic
forms. TbZFP3 expression was relatively uniform during the differentiation time course,
matching the expression of α-tubulin, which is detected with the antibody TAT1.
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FIGURE 2. TbZFP3 ectopic expression generates an enhanced differentiation phenotype
A, a graph shows the percent EP procyclin expressers in either parental cells in the presence
or absence of tetracycline, or in a cell line in which TbZFP3-Ty expression is inducible.
Procyclin expression was monitored for 3 days after exposure of the cells to 6 mM cis-
aconitate by immunofluorescence. The data represent means of four independent
experiments, with the standard error of the mean being presented for each bar. B, during the
differentiation experiments shown in A, the expression of endogenous and ectopic TbZFP3
was monitored using the antibody to TbZFP3. In each case TbZFP-Ty expression was
detected only in the induced population. C, an analysis of EP procyclin expression by flow
cytometry. Cells were processed for staining with antibody to EP procyclin at 48 h after the
initiation of differentiation, and then the proportion of cells expressing this surface marker
was assayed by fluorescence-activated cell sorting. Expression of TbZFP3-Ty enhances the
proportion of cells expressing EP procyclin.
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FIGURE 3. Ectopic expression of TbZFP3-Ty in procyclic forms
A, shows cells in which TbZFP3-Ty expression is induced (or not) by the presence of
tetracycline, together with wild-type controls. In each case TbZFP3 is detected with the
TbZFP3-specific antibody; ectopic expression of TbZFP3-Ty is highly expressed in the
induced cell population, and also present more weakly in the uninduced cell line (due to
incomplete repression). B, shows either a wild-type cell, or a cell that has undergone
morphological extension at its posterior end following induction of the expression of
TbZFP3-Ty. Note that cell dimensions are unchanged, excepting in the distance between the
kinetoplast and cell posterior. N = nucleus, K = kinetoplast.
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FIGURE 4. Nozzle formation as a phenotypic assay for important domains in TbZFP3
A, ectopic expression of either TbZFP3-Ty, or mutant derivatives of this in which the WW
domain is deleted, the CCCH domain is deleted, or in which the third cysteine in the CCCH
domain is mutated to alanine. In each case, expression of the ectopic proteins is detected
with the anti-Ty tag antibody, BB2 (α Ty tag). Also shown are the same samples hybridized
with the TbZFP3-specific anti-peptide antibody, which detects both the transgenic protein
and endogenous TbZFP3. Note that deletion of the WW or CCCH domains causes the
transgenic and endogenous TbZFP3 to co-migrate. In each case equivalent protein loading is
indicated by staining for trypanosome α-tubulin. B, the kinetoplast-posterior dimension for
each cell line either when induced, or not, by the presence of tetracycline. In each case 100
cells were scored, with a horizontal line being placed at the position of the longest
kinetoplast-posterior dimension in the parental population (449) to assist visualization of the
appearance of the nozzle phenotype. One cell in the parental population also showed an
unusually long kinetoplast-posterior dimension: this is seen very occasionally in such
populations but is at a frequency far lower than manifestation of the nozzle phenotype.
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FIGURE 5. Interactions among the TbZFP family assessed by yeast two-hybrid analysis
In each case interactions between intact TbZFP2 or -3 (2DB and 3DB) or mutant derivatives
of these lacking the WW domain (2DB ΔWW and 3DB ΔWW) fused to the LexA DNA
binding domain are shown in combination with TbZFP1, -2, or -3 fused to the Gal4
activation domain (1AD, 2AD, and 3AD). TbZFP1-LexA DNA binding domain constructs
are not included in this analysis, because they autoactivate. TbZFP2 and TbZFP3 LexA
DNA binding domain constructs show no autoactivation (not shown).
Paterou et al. Page 19
J Biol Chem. Author manuscript; available in PMC 2009 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
FIGURE 6. Protein interactions and cellular distribution of TbZFP3
A, co-immunoprecipitation of TbZFP1, -2, and -3 using anti-TbZFP3 antibody. In each case
procyclic cell extracts were subject to immunoprecipitation using anti-ZFP3 antibody and
protein G beads. TbZFP1, -2, and -3 were each immunoprecipitated by TbZFP3-antibody,
the specificity of this interaction being confirmed by inclusion, as a block, of the peptide
immunogen against which the antibody was raised. Consistent with earlier results (16)
TbZFP1 signal is detected as a doublet, the relative intensity of which differs between
experiments for unknown reasons. B, distribution of TbZFP3 in T. brucei bloodstream
(BSF) or procyclic form (PCF) extracts. TbZFP3 associates with the cytosolic fraction, as
does TbZFP2. Analysis of the same extracts with antibodies for alpha tubulin (cytoskeletal
and cytosolic), BiP (endoplasmic reticulum-associated, but with leakage into the cytosol
upon cell fractionation), cytosolic phosphoglycerate kinase (cytosolic) confirmed the
identity of each fraction. No protein associated with the nuclear fraction.
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FIGURE 7. TbZFP3 is polysome-associated in procyclic forms
Procyclic form cell extracts were separated on 15-50% sucrose gradients, and the presence
of TbZFP3, the ribosomal protein P0, and the non-ribosomal endoplasmic reticulum protein
BiP were detected via specific antibodies against each protein. Lower molecular weight
fractions are to the left of each profile, high molecular weight polysomal fractions are to the
right. Extracts were prepared in the presence of cycloheximide or in the presence of EDTA,
which disassociates polysomes causing redistribution of TbZFP3 and P0 into lower
molecular weight fractions.
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FIGURE 8. Stage-specific polysome association of TbZFP3
A, polysome association of TbZFP3 is procyclic-enriched. The distribution of TbZFP3 or
the ribosomal protein P0 is shown in either procyclic forms, bloodstream slender forms, or
bloodstream stumpy forms. B, ectopic expression of TbZFP3 in procyclic and bloodstream
forms. In each case the ectopic protein (which runs slightly larger than the endogenous
protein due to the incorporation of a C-terminal Ty epitope tag) co-sediments with the
endogenous protein, this being polysomal in procyclic forms, and non-polysomal in
bloodstream forms.
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FIGURE 9. Polysomal association of TbZFP3 mutants
Ectopic expression of either TbZFP-ΔWW, TbZFP3-CCAH, or TbZFP3-ΔCCCH was
induced in procyclic forms, and the distribution of endogenous and ectopic TbZFP3 was
detected using the TbZFP3-specific antibody (α-TbZFP3). Specific detection of the ectopic
protein was via antibody to the Ty1-eptiope tag incorporated into each mutant protein (α-
Ty1). The polysomal distribution was determined by antibody to the P0 protein (α-P0). Note
that the ΔCCCH and ΔWW mutants co-migrate with endogenous TbZFP3, whereas the
CCAH mutant runs slightly larger than endogenous TbZFP2 (due to incorporation of the
Ty1 epitope tag).
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FIGURE 10. Differentiation capacity of bloodstream forms expressing mutant TbZFP3
Differentiation efficiency of transgenic bloodstream lines expressing under tetracycline
regulation either intact TbZFP3 or mutants disrupted for the CCCH domain (CCAH or
ΔCCCH) or WW domain. The expression of EP procyclin was scored by
immunofluorescence after 24, 48, or 72 h. Data represent the mean of four independent
experiments, with error bars demonstrating the standard error.
Paterou et al. Page 24
J Biol Chem. Author manuscript; available in PMC 2009 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
FIGURE 11. Immunoprecipitation of EP procyclin transcripts with TbZFP3
A, EP procyclin mRNA is selected by immunoprecipitation of TbZFP3. Lane 1, EP
procyclin cDNA amplification after immunoprecipitation with TbZFP3-specific antibody;
lane 2, as lane 1, but with immunoprecipitation being blocked by the TbZFP3 peptide
immunogen; lane 3, EP procyclin cDNA amplified from reverse transcribed procyclic form
total RNA; lane 4, as lane 3 but without reverse transcriptase; lane 5, as lane 3 but without
inclusion of procyclic form mRNA; lane 6, T. brucei genomic DNA in place of procyclic
form total RNA; lane 7, water in place of procyclic form mRNA; lane 8, marker. B,
immunoprecipitation of TbZFP3 differentially selects EP procyclin mRNA with respect to a
constitutively expressed transcript. cDNA was derived after RNA immunoprecipitation with
anti-TbZFP3 antibody, or derived from unselected total RNA. In each case, an equivalent
amount of cDNA was amplified with primers specific for EP procyclin or the constitutively
expressed transcript actin in combination with an oligo(dT) anchor, to amplify the 3′-end of
each transcript. All amplification reactions were carried out simultaneously with the same
source material being used for each. Reaction products were with-drawn every 5 cycles for
35 cycles. EP procyclin mRNA was selected in the immunoprecipitation, whereas actin
mRNA was not. In total RNA both transcripts were amplified, with actin mRNA being
detected before EP procyclin.
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